Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nutex Health Inc.NUTX · Entity 4803 | Chief Legal Officer-Healthcare | March 13, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nutex Health Inc.
Report date March 13, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,758 |
Reported balance
After 2026-03-13 transaction · row 1
1 source rowRow 1 · 2026-03-13 · Purchase · Acquired 79 · Balance 2,758 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-03-01 | Direct | 4,441 |
Reported balance
After 2026-03-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-10 · Exercise / conversion · Acquired 1,523 · Balance 4,441 F1: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 10, 2026 relating to a transaction dated March 10, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 10, 2026 relating to a transaction dated March 10, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2026 Filed Mar 16, 2026 19:02 UTC | Nutex Health Inc. NUTX · Entity 4803 | PurchaseCommon Stock | 79 | $88.87 | $7,020.72 |
DisclosureSEC source: 0001919434-26-000002 · primary_doc.xml · nonDerivative · entry 1 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,758 Read SEC document |
| March 10, 2026 Filed Mar 11, 2026 22:08 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionRestricted Stock Units · Derivative | 1,525 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001919434-26-000001 · primary_doc.xml · derivative · entry 3 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,217 Underlying: Common Stock · 1,525 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units that convert into common stock on a one-for-one basis upon vesting. F1 · shares: Restricted stock units that convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. F3 · derivative.expiration_date: On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. Read SEC document |
| March 10, 2026 Filed Mar 11, 2026 22:08 UTC | Nutex Health Inc. NUTX · Entity 4803 | Tax withholdingCommon Stock | 776 | $86.22 | $66,908.58 |
DisclosureSEC source: 0001919434-26-000001 · primary_doc.xml · nonDerivative · entry 2 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,679 F2 · shares: Of the 2,084 shares issued subsequent to vesting, 776 shares were sold to cover tax withholding obligations. Read SEC document |
| March 10, 2026 Filed Mar 11, 2026 22:08 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionCommon Stock | 2,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001919434-26-000001 · primary_doc.xml · nonDerivative · entry 1 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units that convert into common stock on a one-for-one basis upon vesting. F1 · price: Restricted stock units that convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| March 10, 2026 Filed Mar 16, 2026 19:02 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionRestricted Stock Unit · Derivative | 1,523 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001919434-26-000002 · primary_doc.xml · derivative · entry 2 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,441 Underlying: Common Stock · 1.523 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 10, 2026 relating to a transaction dated March 10, 2026. F1 · derivative.underlying_shares: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 10, 2026 relating to a transaction dated March 10, 2026. Read SEC document |
| April 04, 2025 Filed Apr 14, 2025 19:50 UTC | Nutex Health Inc. NUTX · Entity 4803 | Tax withholdingCommon Stock | 266 | $72.10 | $19,177.86 |
DisclosureSEC source: 0001486189-25-000014 · primary_doc.xml · nonDerivative · entry 4 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,371 F3 · shares: Of the 1,250 shares issued subsequent to vesting, 266 shares were sold to cover tax withholding obligations. Read SEC document |
| April 04, 2025 Filed Apr 14, 2025 19:50 UTC | Nutex Health Inc. NUTX · Entity 4803 | Tax withholdingCommon Stock | 24 | $72.10 | $1,730.33 |
DisclosureSEC source: 0001486189-25-000014 · primary_doc.xml · nonDerivative · entry 2 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 387 F2 · shares: Of the 111 shares issued subsequent to vesting, 24 shares were sold to cover tax withholding obligations. Read SEC document |
| March 10, 2025 Filed Apr 14, 2025 19:50 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001486189-25-000014 · primary_doc.xml · derivative · entry 5 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,500 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028. F4 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028. Read SEC document |
| March 01, 2025 Filed Apr 14, 2025 19:50 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001486189-25-000014 · primary_doc.xml · nonDerivative · entry 3 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 01, 2025 Filed Apr 14, 2025 19:50 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionCommon Stock | 111 | $0.00 | $0.00 |
DisclosureSEC source: 0001486189-25-000014 · primary_doc.xml · nonDerivative · entry 1 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 28, 2024 Filed Jun 28, 2024 16:11 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantRestricted Stock Unit · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001486189-24-000035 · primary_doc.xml · derivative · entry 1 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,601 Underlying: Common Stock · 37,500 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated June 28, 2024, the 37,500 RSUs granted to Ms. Montgomery will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027. F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated June 28, 2024, the 37,500 RSUs granted to Ms. Montgomery will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027. F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 20:33 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionRestricted Stock Units · Derivative | 16,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001486189-24-000019 · primary_doc.xml · derivative · entry 2 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,501 Underlying: Common Stock · 16,502 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F3 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025. F3 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025. F2 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 20:33 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionCommon Stock | 16,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001486189-24-000019 · primary_doc.xml · nonDerivative · entry 1 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on March 1, 2024 through the issuance of shares of Common Stock. F2 · price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 15:50 UTC | Nutex Health Inc. NUTX · Entity 4803 | PurchaseCommon Stock | 12,000 | $0.43 | $5,140.80 |
DisclosureSEC source: 0001486189-23-000004 · primary_doc.xml · nonDerivative · entry 1 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,502 Read SEC document |
| April 01, 2023 Filed May 10, 2023 19:52 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionRestricted Stock Unit · Derivative | 16,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-010662 · form4.xml · derivative · entry 3 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,003 Underlying: Common Stock · 16,502 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025. F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025. F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. Read SEC document |
| April 01, 2023 Filed May 10, 2023 19:52 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantRestricted Stock Unit · Derivative | 49,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-010662 · form4.xml · derivative · entry 2 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,505 Underlying: Common Stock · 49,505 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025. F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025. F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. Read SEC document |
| April 01, 2023 Filed May 10, 2023 19:52 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionCommon Stock | 16,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-010662 · form4.xml · nonDerivative · entry 1 Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.